Epidural tramadol for postoperative pain relief

Area of Science:

• Anesthesiology
• Pharmacology
• Pain Management

Background:

• Postoperative pain management is crucial for patient recovery.
• Epidural analgesia is a common method for managing severe pain.
• Tramadol hydrochloride is a centrally acting analgesic with potential for epidural use.

Purpose of the Study:

• To evaluate the efficacy of epidural tramadol hydrochloride for postoperative pain relief.
• To compare the effectiveness of different doses of epidural tramadol (50 mg and 100 mg) against bupivacaine.
• To assess pain scores, dose interval, and side effects associated with epidural tramadol.

Main Methods:

• Sixty patients undergoing abdominal surgery were randomized into three groups.
• Group 1 received 50 mg epidural tramadol, Group 2 received 100 mg epidural tramadol, and Group 3 received 0.25% bupivacaine.
• Pain scores (visual analogue scale), vital signs, blood gases, and side effects were monitored over 24 hours with patient-controlled dosing (max 4 doses).

Main Results:

• The 100 mg epidural tramadol group showed significantly lower pain scores at 3, 12, and 24 hours compared to the 50 mg tramadol and bupivacaine groups (p < 0.05).
• The mean interval between doses was significantly longer in the 100 mg tramadol group (9.36 h) compared to the bupivacaine group (5.98 h) (p < 0.05).
• The incidence of nausea and vomiting was significantly higher in the 100 mg tramadol group compared to the bupivacaine group (p < 0.05).

Conclusions:

• Epidural administration of 100 mg tramadol hydrochloride provides superior postoperative pain relief compared to 50 mg and epidural bupivacaine.
• Higher efficacy of 100 mg epidural tramadol is associated with a longer duration of action.
• Increased incidence of nausea and vomiting with 100 mg epidural tramadol necessitates careful patient monitoring.